Delay in Insurance Approval of Biologic Therapy Dose Escalation Is Associated With Increased Disease Activity in Patients With Inflammatory Bowel Disease

被引：0
|
作者：
Shah, Nisha [1 ]
Cherry, Laura [1 ]
Zuckerman, Autumn [1 ]
Vimalathas, Praveen [1 ]
Choi, Leena [1 ]
Donoho, Charles A. [1 ]
Pabla, Baldeep [1 ]
Scoville, Elizabeth [1 ]
Dalal, Robin [1 ]
Beaulieu, Dawn [1 ]
Schwartz, David [1 ]
Horst, Sara [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S833
引用
收藏
页码：S385 / S385
页数：1
相关论文
共 50 条
  • [41] VEDOLIZUMAB DOSE ESCALATION AS A WAY OF RECAPTURING RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Birdi, S.
    Sierra Morales, M.
    Samaan, M. A.
    Brown-Clarke, C.
    Stanton, A.
    Ray, S.
    Koumoutsos, I.
    Mawdsley, J.
    Anderson, S.
    Sandersdon
    Irving, P. M.
    GUT, 2018, 67 : A69 - A70
  • [42] FACTORS ASSOCIATED WITH EARLY BIOLOGIC DISCONTINUATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Cusumano, Vivy T.
    Sauk, Jenny S.
    Limketkai, Berkeley N.
    GASTROENTEROLOGY, 2023, 164 (06) : S1124 - S1125
  • [43] De-escalation of Therapy in Inflammatory Bowel Disease
    Frias Gomes C.
    Colombel J.-F.
    Torres J.
    Current Gastroenterology Reports, 2018, 20 (8)
  • [44] Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study
    Zissimopoulos, Athanasios
    Vradelis, Stergios
    Konialis, Manolis
    Chadolias, Dimitrios
    Bampali, Asimenia
    Constantinidis, Theodoros
    Efremidou, Eleni
    Kouklakis, George
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (08) : 942 - 949
  • [45] Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study
    Vradelis, Stergios
    Kouklakis, George
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (11) : 1397 - 1397
  • [46] Inflammatory bowel disease surgery in the biologic therapy era
    Strong, Scott A.
    CURRENT OPINION IN GASTROENTEROLOGY, 2012, 28 (04) : 349 - 353
  • [47] The Role of Dual Biologic Therapy in Inflammatory Bowel Disease
    Molly, Stone
    Margaret, Morrison
    Erin, Forster
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S20 - S20
  • [48] Biologic therapy for inflammatory bowel disease comes of age
    Hanauer S.B.
    Current Gastroenterology Reports, 2007, 9 (6) : 485 - 488
  • [49] Adalimumab Concentrations Following Dose Escalation in Inflammatory Bowel Disease
    Jasurda, Jake
    McCabe, Robert
    Vaughn, Byron
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S437 - S438
  • [50] OUTCOMES OF DOSE ESCALATION WITH ADALIMUMAB (ADA) IN INFLAMMATORY BOWEL DISEASE
    Dillon, A.
    Rowan, C.
    Gibson, D.
    Keegan, D.
    Byrne, K.
    Mulcahy, H.
    Cullen, G.
    Doherty, G.
    GUT, 2013, 62
12345